重新出现的抗脂综合征:一种除了凝血之外的血栓炎症疾病
Catherine B Ducker1, Megan V Preece1, Charis Pericleous2
1Centre for Haematology, Department of immunology and Inflammation, Imperial College London, London, United Kingdom.
Blood reviews
|February 27, 2026
概括
血栓炎症是抗脂综合征 (APS) 的一个关键特征,涉及到导致血栓的免疫失调. 了解这一过程对于开发新疗法至关重要,这些疗法超出了APS患者目前的抗凝疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 血栓炎症描述了免疫血栓形成的失调.
- 抗脂综合征 (APS) 是一种自身免疫性疾病,其特征是抗脂抗体 (aPL),炎症和血栓形成.
- aPL抗体通过影响免疫细胞,血小板和内皮,促进了前炎和前血栓状态.
研究的目的:
- 审查内皮功能障碍和血栓炎症在血栓性APS中的作用.
- 探索如何理解血栓炎症可以为APS提供新的治疗策略.
主要方法:
- 文献综述侧重于APS中的内皮功能障碍和血栓炎症.
- 对aPL抗体诱导前血栓和炎症状态的机制的分析.
- 检查当前的治疗策略及其局限性.
主要成果:
- 抗脂抗体 (aPL) 直接和间接地影响单细胞,中性粒细胞,血小板和内皮细胞.
- 凝血和补充通路的aPL激活有助于血栓形成.
- 目前的抗凝治疗不能解决内皮功能障碍或炎症,这可能解释了复发性血栓形成.
结论:
- 血栓炎症是血栓性APS病变的核心原因.
- 向内皮功能障碍和炎症途径可能为APS提供了改进的治疗选择.
- 对血栓炎症的进一步研究可能会导致APS的新或重新定位的疗法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Venous Thrombosis I: Introduction
580
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
580
Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Peripheral Artery Disease I: Introduction
490
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
490
Extrinsic and Intrinsic Pathways of Hemostasis
14.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.1K
Inflammation
62.8K
Overview
62.8K


